← back to search

David Goodman‐Meza

Office of Infectious Diseases · US
Area of research
Public Health, Environmental and Occupational Health · Epidemiology
Research interest
Research interests include Opioid Use Disorder Treatment, HIV, Drug Use, Sexual Risk, Forensic Toxicology and Drug Analysis, and HIV/AIDS Research and Interventions.
h-index
25
citations
3,467
works
106
NIH funding
primary concept
Medicine
email

Recent publications

A phase 3 randomised double-blind placebo-controlled trial of mirtazapine as a pharmacotherapy for methamphetamine use disorder: a study protocol for the Tina Trial
Trials 2024cited by 7position: middledoi
Fentanyl, heroin, and methamphetamine-based counterfeit pills sold at tourist-oriented pharmacies in Mexico: An ethnographic and drug checking study
Drug and Alcohol Dependence 2023cited by 33position: middledoi
Intersections between syndemic conditions and stages along the continuum of overdose risk among women who inject drugs in Mexicali, Mexico
Harm Reduction Journal 2023cited by 7position: lastdoi
Xylazine spreads across the US: A growing component of the increasingly synthetic and polysubstance overdose crisis
Drug and Alcohol Dependence 2022cited by 351position: middledoi
Perspectives on preparing for long-acting injectable treatment for HIV among consumer, clinical and nonclinical stakeholders: A qualitative study exploring the anticipated challenges and opportunities for implementation in Los Angeles County
PLoS ONE 2022cited by 52position: middledoi
Frequency of reported methamphetamine use linked to prevalence of clinical conditions, sexual risk behaviors, and social adversity in diverse men who have sex with men in Los Angeles
Drug and Alcohol Dependence 2022cited by 35position: middledoi
Natural Language Processing and Machine Learning to Identify People Who Inject Drugs in Electronic Health Records
Open Forum Infectious Diseases 2022cited by 21position: firstdoi
Behavior change after fentanyl testing at a safe consumption space for women in Northern Mexico: A pilot study
International Journal of Drug Policy 2022cited by 19position: firstdoi
Rapid Adoption of Low-Threshold Buprenorphine Treatment at California Emergency Departments Participating in the CA Bridge Program
Annals of Emergency Medicine 2021cited by 90position: middledoi
Primary, Recall, and Decay Kinetics of SARS-CoV-2 Vaccine Antibody Responses
ACS Nano 2021cited by 89position: middledoi
Rapid Decay of Anti–SARS-CoV-2 Antibodies in Persons with Mild Covid-19
New England Journal of Medicine 2020cited by 1,156position: middledoi
A machine learning algorithm to increase COVID-19 inpatient diagnostic capacity
PLoS ONE 2020cited by 71position: firstdoi
Collective Call to Action for HIV/AIDS Community-Based Collaborative Science in the Era of COVID-19
AIDS and Behavior 2020cited by 47position: middledoi
Association between self-reported marijuana use and incident diabetes in women and men with and at risk for HIV
Drug and Alcohol Dependence 2020cited by 10position: middledoi
<p>Depot Buprenorphine Injection In The Management Of Opioid Use Disorder: From Development To Implementation</p>
Substance Abuse and Rehabilitation 2019cited by 50position: lastdoi
Methamphetamine use drives decreases in viral suppression for people living with HIV released from a large municipal jail: Results of the LINK LA clinical trial
Drug and Alcohol Dependence 2019cited by 28position: firstdoi
Accuracy of Transcranial Doppler for the Diagnosis of Intracardiac Right-to-Left Shunt
JACC. Cardiovascular imaging 2014cited by 198position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Steven Shoptaw · University of California, Los Angeles10 papers (2019–2023)Jennifer A. Fulcher · University of California, San Francisco3 papers (2020–2021)Julie Elliott · University of California, Los Angeles2 papers (2020–2021) · 2 papers (2022–2023)Mary Ann Hausner · University of California, Los Angeles2 papers (2020–2021)F. Javier Ibarrondo · Black AIDS Institute2 papers (2020–2021) · 2 papers (2022–2023)Nicole H. Tobin · University of California System2 papers (2020–2021)Chelsea L. Shover · Los Angeles County Department of Health Services2 papers (2022–2023)Joseph Friedman · Boston Health Care for the Homeless Program2 papers (2022–2023)Michael J. Li · University of California, Los Angeles2 papers (2020–2022)Raphael J. Landovitz · APLA Health2 papers (2020–2022) · 2 papers (2022–2023)Otto O. Yang · UCLA Medical Center2 papers (2020–2021) · 2 papers (2022–2023)Kathie G. Ferbas · University of California, Los Angeles2 papers (2020–2021)Mary Catherine Cambou · University of California, Los Angeles2 papers (2022–2023)Jaime Arredondo · University of Victoria2 papers (2022–2023)Grace M. Aldrovandi · University of California System2 papers (2020–2021)Philippe Bourgois · University of California, Los Angeles1 papers (2023–2023)